Behcet's syndrome
RecruitingStudy on Apremilast for Treating Oral Ulcers in Children with Behçet's Disease
- Disease:Behcet's syndrome
- Substances:Apremilast
Italy- Participants:0–17 years
- Substances:Apremilast
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Italy113 clinical trials in Chieti, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple sclerosis treatments and management of Parkinson's disease. Clinical trials are evaluating new therapeutic approaches including frexalimab for relapsing MS and novel subcutaneous infusion therapies for advanced Parkinson's.
Comprehensive studies examining treatments for type 2 diabetes and cardiovascular conditions. Research includes evaluation of tirzepatide and innovative approaches for stroke prevention in patients with atrial fibrillation.
Advanced research in chronic kidney disease and end-stage renal disease, investigating novel dialysis solutions and treatment combinations. Studies focus on improving outcomes for patients requiring peritoneal dialysis.
Clinical investigations of treatments for atopic dermatitis and other skin conditions. Studies evaluate new biological therapies and targeted treatments for various dermatological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.